Referee report. For: Improving the predictive power of xenograft and syngeneic anti-tumour studies using mice humanised for pathways of drug metabolism [version 1; peer review: 2 approved with reservations] (2023)
Attributed to:
Developing new paradigms for overcoming drug resistance in cancer using novel humanised mouse models
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.5256/f1000research.135046.r160109
Publication URI: https://f1000research.com/articles/11-1081/v1#referee-response-160109
Type: Other